Physician profile
Stacey Michelle Nedrud
NPI 1891113205
$5,309.96
in general payments reported to CMS, 2019-2025
11 companies · $3,424 in 2025
The $3,424 reported for 2025 was more than what 93% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $273 · 2022: $328 · 2023: $511 · 2024: $774 · 2025: $3,424.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $2,000 · Food and Beverage: $1,691 · Travel and Lodging: $1,018.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $2,000.00 |
| Food and Beverage | $1,691.19 |
| Travel and Lodging | $1,017.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $3,693.07 | 2022-2025 | |
| Axogen | $460.08 | 2022-2024 | Avance Nerve Graft, Axoguard Nerve Cap, Axoguard Ha+ Nerve Protector |
| Inspire Medical Systems, INC. | $374.87 | 2023-2025 | Inspire |
| Medical Device Business Services, INC. | $178.00 | 2021 | |
| Depuy Synthes Sales INC. | $166.11 | 2023-2025 | Trumatch, Na, Matrixmidface |
| Straumann USA LLC | $128.45 | 2025 | |
| Stryker Corporation | $98.02 | 2022 | |
| Checkpoint Surgical, INC | $94.96 | 2021 | |
| Zest Holdings, LLC | $77.67 | 2024 | |
| Integra Lifesciences Corporation | $20.08 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Ambu INC. | $18.65 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacey Nedrud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.